Winchester DP. The assurance of quality care for the cancer patient. Cancer 1990;65(3 Suppl):776–779.

• Crossref
• PubMed
Winchester DP. The assurance of quality care for the cancer patient. Cancer 1990;65(3 Suppl):776–779.10.1002/1097-0142(19900201)65:3+<776::AID-CNCR2820651324>3.0.CO;2-O2302655)| false
• Search Google Scholar
• Export Citation

Ayanian JZ, Markel H. Donabedian’s lasting framework for health care quality. N Engl J Med 2016;375:205–207.

• Crossref
• PubMed
Ayanian JZ, Markel H. Donabedian’s lasting framework for health care quality. N Engl J Med 2016;375:205–207.10.1056/NEJMp160510127468057)| false
• Search Google Scholar
• Export Citation

Rosati RJ. The history of quality measurement in home health care. Clin Geriatr Med 2009;25:121–134.

• Crossref
• PubMed
Rosati RJ. The history of quality measurement in home health care. Clin Geriatr Med 2009;25:121–134.1921749710.1016/j.cger.2008.11.001)| false
• Search Google Scholar
• Export Citation

Department of Health and Human Services. Updates to the Quality Payment Program. Fed Regist 2019;84:40482–41289. Section III.K. Available at: https://www.govinfo.gov/content/pkg/FR-2019-08-14/pdf/2019-16041.pdf. Accessed November 1, 2019.

• PubMed
Department of Health and Human Services. Updates to the Quality Payment Program. Fed Regist 2019;84:40482–41289. Section III.K. Available at: https://www.govinfo.gov/content/pkg/FR-2019-08-14/pdf/2019-16041.pdf. Accessed November 1, 2019.)| false
• Export Citation

Oncology Care First Model: informal request for information. Available at: https://innovation.cms.gov/Files/x/ocf-informalrfi.pdf. Accessed November 13, 2019.

• PubMed
Oncology Care First Model: informal request for information. Available at: https://innovation.cms.gov/Files/x/ocf-informalrfi.pdf. Accessed November 13, 2019.)| false
• Export Citation

Miniemyer P. Blues plans to launch high-performance network nationwide in 2021. FierceHealthcare.com. Available at: https://www.fiercehealthcare.com/payer/blues-plans-to-launch-high-performance-network-nationwide-2021. Accessed November 13, 2019.

• PubMed
Miniemyer P. Blues plans to launch high-performance network nationwide in 2021. FierceHealthcare.com. Available at: https://www.fiercehealthcare.com/payer/blues-plans-to-launch-high-performance-network-nationwide-2021. Accessed November 13, 2019.)| false
• Export Citation

U.S. Department of Health and Human Services. HHS Quality Summit (QS) Fact Sheet. Available at: https://www.hhs.gov/about/news/2019/07/09/hhs-quality-summit-fact-sheet.html. Accessed November 13, 2019.

• PubMed
U.S. Department of Health and Human Services. HHS Quality Summit (QS) Fact Sheet. Available at: https://www.hhs.gov/about/news/2019/07/09/hhs-quality-summit-fact-sheet.html. Accessed November 13, 2019.)| false
• Export Citation

Centers for Medicare & Medicaid Services. Trump Administration’s Patients Over Paperwork delivers for doctors. Available at: https://www.cms.gov/newsroom/press-releases/trump-administrations-patients-over-paperwork-delivers-doctors. Accessed December 1, 2019.

• PubMed
Centers for Medicare & Medicaid Services. Trump Administration’s Patients Over Paperwork delivers for doctors. Available at: https://www.cms.gov/newsroom/press-releases/trump-administrations-patients-over-paperwork-delivers-doctors. Accessed December 1, 2019.)| false
• Export Citation

American Cancer Society. Cancer Facts & Figures 2015. Available at: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2015.html. Accessed October 3, 2019.

• PubMed
American Cancer Society. Cancer Facts & Figures 2015. Available at: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2015.html. Accessed October 3, 2019.)| false
• Export Citation

American College of Surgeons. CoC Quality Care Measures. Available at: https://www.facs.org/quality-programs/cancer/ncdb/qualitymeasures. Accessed December 1, 2019

• PubMed
American College of Surgeons. CoC Quality Care Measures. Available at: https://www.facs.org/quality-programs/cancer/ncdb/qualitymeasures. Accessed December 1, 2019)| false
• Export Citation

American Society of Clinical Oncology. Don’t perform surveillance testing (biomarkers) or imaging (PET, CT, and radionuclide bone scans) for asymptomatic individuals who have been treated for breast cancer with curative intent. ChoosingWisely.org. Available at: https://www.choosingwisely.org/clinician-lists/american-society-clinical-oncology-surveillance-testing-imaging-for-breast-cancer/. Accessed December 1, 2019.

• PubMed
American Society of Clinical Oncology. Don’t perform surveillance testing (biomarkers) or imaging (PET, CT, and radionuclide bone scans) for asymptomatic individuals who have been treated for breast cancer with curative intent. ChoosingWisely.org. Available at: https://www.choosingwisely.org/clinician-lists/american-society-clinical-oncology-surveillance-testing-imaging-for-breast-cancer/. Accessed December 1, 2019.)| false
• Export Citation

ASCO QOPI. QOPI 2019 Reporting Tracks. Available at: https://practice.asco.org/sites/default/files/drupalfiles/QOPI-2019-Round-1-Reporting-Tracks-Public-Posting.pdf. Accessed November 1, 2019.

• PubMed
ASCO QOPI. QOPI 2019 Reporting Tracks. Available at: https://practice.asco.org/sites/default/files/drupalfiles/QOPI-2019-Round-1-Reporting-Tracks-Public-Posting.pdf. Accessed November 1, 2019.)| false
• Export Citation

Quality ID #455 (NQF 0213): percentage of patients who died from cancer admitted to the intensive care unit (ICU) in the last 30 days of life. Available at: https://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2019_Measure_455_MIPSCQM.pdf. Accessed December 1, 2019.

• PubMed
Quality ID #455 (NQF 0213): percentage of patients who died from cancer admitted to the intensive care unit (ICU) in the last 30 days of life. Available at: https://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2019_Measure_455_MIPSCQM.pdf. Accessed December 1, 2019.)| false
• Export Citation

Department of Health and Human Services. CY 2020 Quality Reporting Requirements for Specific Providers. Fed Regist 2019;84:42044–42701. Section VIII. Available at: https://www.govinfo.gov/content/pkg/FR-2019-08-16/pdf/2019-16762.pdf. Accessed November 1, 2019.

• PubMed
Department of Health and Human Services. CY 2020 Quality Reporting Requirements for Specific Providers. Fed Regist 2019;84:42044–42701. Section VIII. Available at: https://www.govinfo.gov/content/pkg/FR-2019-08-16/pdf/2019-16762.pdf. Accessed November 1, 2019.)| false
• Export Citation

Proportion of patients who died of cancer admitted to the ICU in the last 30 days of life. National Quality Forum. National Quality Forum Endorsed Measures Database Website. Available at: http://www.qualityforum.org/QPS/. Accessed December 1, 2019.

• PubMed
Proportion of patients who died of cancer admitted to the ICU in the last 30 days of life. National Quality Forum. National Quality Forum Endorsed Measures Database Website. Available at: http://www.qualityforum.org/QPS/. Accessed December 1, 2019.)| false
• Export Citation

Quality ID #226 (NQF 0028): preventive care and screening: tobacco use: screening and cessation intervention. Available at: https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2019_Measure_226_MedicarePartBClaims.pdf. Accessed December 1, 2019.

• PubMed
Quality ID #226 (NQF 0028): preventive care and screening: tobacco use: screening and cessation intervention. Available at: https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2019_Measure_226_MedicarePartBClaims.pdf. Accessed December 1, 2019.)| false
• Export Citation

National Quality Forum. Preventive care and screening: tobacco use: screening and cessation intervention. Available at: http://www.qualityforum.org/QPS/0028. Accessed December 1, 2019

• PubMed
National Quality Forum. Preventive care and screening: tobacco use: screening and cessation intervention. Available at: http://www.qualityforum.org/QPS/0028. Accessed December 1, 2019)| false
• Export Citation

Quality ID #453 (NQF 0210): percentage of patients who died of cancer receiving chemotherapy in the last 14 days of life. Available at: https://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2019_Measure_453_MIPSCQM.pdf. Accessed December 8, 2019.

• PubMed
Quality ID #453 (NQF 0210): percentage of patients who died of cancer receiving chemotherapy in the last 14 days of life. Available at: https://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2019_Measure_453_MIPSCQM.pdf. Accessed December 8, 2019.)| false
• Export Citation

National Quality Forum. Proportion of patients who died of cancer receiving chemotherapy in the last 14 days of life. Available at: http://www.qualityforum.org/QPS/0210. Accessed December 1, 2019.

• PubMed
National Quality Forum. Proportion of patients who died of cancer receiving chemotherapy in the last 14 days of life. Available at: http://www.qualityforum.org/QPS/0210. Accessed December 1, 2019.)| false
• Export Citation

American College of Surgeons, Commission on Cancer. Oncology Medical Home Accreditation Program Standards Manual. Available at: https://www.facs.org/∼/media/files/quality%20programs/cancer/coc/omh%20manual.ashx. Accessed November 15, 2019.

• PubMed
American College of Surgeons, Commission on Cancer. Oncology Medical Home Accreditation Program Standards Manual. Available at: https://www.facs.org/∼/media/files/quality%20programs/cancer/coc/omh%20manual.ashx. Accessed November 15, 2019.)| false
• Export Citation

National Quality Forum. Oncology: cancer stage documented. Available at: http://www.qualityforum.org/QPS/0386. Accessed December 1, 2019.

• PubMed
National Quality Forum. Oncology: cancer stage documented. Available at: http://www.qualityforum.org/QPS/0386. Accessed December 1, 2019.)| false
• Export Citation

National Quality Forum. Proportion dying from cancer in an acute care setting. Available at: http://www.qualityforum.org/QPS/0214. Accessed December 1, 2019.

• PubMed
National Quality Forum. Proportion dying from cancer in an acute care setting. Available at: http://www.qualityforum.org/QPS/0214. Accessed December 1, 2019.)| false
• Export Citation

National Quality Forum. Proportion of patients who died of cancer not admitted to hospice. Available at: http://www.qualityforum.org/QPS/0215. Accessed December 1, 2019

• PubMed
National Quality Forum. Proportion of patients who died of cancer not admitted to hospice. Available at: http://www.qualityforum.org/QPS/0215. Accessed December 1, 2019)| false
• Export Citation

Oncology Care Model. OCM performance-based payment methodology, Version 3.2. Available at: https://innovation.cms.gov/Files/x/ocm-cancercodelists.pdf. Accessed December 1, 2019.

• PubMed
Oncology Care Model. OCM performance-based payment methodology, Version 3.2. Available at: https://innovation.cms.gov/Files/x/ocm-cancercodelists.pdf. Accessed December 1, 2019.)| false
• Export Citation

National Quality Forum. Prostate cancer: combination androgen deprivation therapy for high risk or very high risk prostate cancer. Available at: http://www.qualityforum.org/QPS/0390. Accessed December 1, 2019

• PubMed
National Quality Forum. Prostate cancer: combination androgen deprivation therapy for high risk or very high risk prostate cancer. Available at: http://www.qualityforum.org/QPS/0390. Accessed December 1, 2019)| false
• Export Citation

Localized prostate cancer: urinary incontinence. Centers for Medicare & Medicaid Services Measures Inventory Tool. Available at: https://cmit.cms.gov/CMIT_public/ViewMeasure?MeasureId=5656. Accessed December 3, 2019.

• PubMed
Localized prostate cancer: urinary incontinence. Centers for Medicare & Medicaid Services Measures Inventory Tool. Available at: https://cmit.cms.gov/CMIT_public/ViewMeasure?MeasureId=5656. Accessed December 3, 2019.)| false
• Export Citation

Localized prostate cancer: vitality. Centers for Medicare & Medicaid Services Measures Inventory Tool. Available at: https://cmit.cms.gov/CMIT_public/ViewMeasure?MeasureId=5657. Accessed December 3, 2019.

• PubMed
Localized prostate cancer: vitality. Centers for Medicare & Medicaid Services Measures Inventory Tool. Available at: https://cmit.cms.gov/CMIT_public/ViewMeasure?MeasureId=5657. Accessed December 3, 2019.)| false
• Export Citation

National Quality Forum. History of Prostate Cancer - Cancer Surveillance. Available at: http://www.qualityforum.org/QPS/0625. Accessed December 1, 2019.

• PubMed
National Quality Forum. History of Prostate Cancer - Cancer Surveillance. Available at: http://www.qualityforum.org/QPS/0625. Accessed December 1, 2019.)| false
• Export Citation

McGale P, Taylor C, Correa C, et al.. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014;383:2127–2135.

• Crossref
• PubMed
McGale P, Taylor C, Correa C, . Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014;383:2127–2135.2465668510.1016/S0140-6736(14)60488-8)| false
• Search Google Scholar
• Export Citation

Gradishar WJ, Anderson BO, Abraham J, et al.. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 3.2019. Accessed November 27, 2019. For the most recent version, visit NCCN.org.

• PubMed
Gradishar WJ, Anderson BO, Abraham J, . NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 3.2019. Accessed November 27, 2019. For the most recent version, visit NCCN.org.)| false
• Export Citation

Hahn EE, Hays RD, Kahn KL, et al.. Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors. Cancer 2013;119:4316–4324.

• Crossref
• PubMed
Hahn EE, Hays RD, Kahn KL, . Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors. Cancer 2013;119:4316–4324.10.1002/cncr.2836324105101)| false
• Search Google Scholar
• Export Citation

Khatcheressian JL, Hurley P, Bantug E, et al.. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:961–965.

• Crossref
• PubMed
Khatcheressian JL, Hurley P, Bantug E, . Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:961–965.10.1200/JCO.2012.45.9859)| false
• Search Google Scholar
• Export Citation

Seidman A, Hudis C, Pierri MK, et al.. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 2002;20:1215–1221.

• Crossref
• PubMed
Seidman A, Hudis C, Pierri MK, . Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 2002;20:1215–1221.1187016310.1200/JCO.20.5.1215)| false
• Search Google Scholar
• Export Citation

Moja L, Tagliabue L, Balduzzi S, et al.. Trastuzumab containing regimens for early breast cancer. Cochrane Database Syst Rev 2012:CD006243.

• PubMed
Moja L, Tagliabue L, Balduzzi S, . Trastuzumab containing regimens for early breast cancer. Cochrane Database Syst Rev 2012:CD006243.22513938)| false
• Search Google Scholar
• Export Citation

Balduzzi S, Mantarro S, Guarneri V, et al.. Trastuzumab-containing regimens for metastatic breast cancer. Cochrane Database Syst Rev 2014:CD006242.

• PubMed
Balduzzi S, Mantarro S, Guarneri V, . Trastuzumab-containing regimens for metastatic breast cancer. Cochrane Database Syst Rev 2014:CD006242.24919460)| false
• Search Google Scholar
• Export Citation

Henry ML, Niu J, Zhang N, et al.. Cardiotoxicity and cardiac monitoring among chemotherapy-treated breast cancer patients. JACC Cardiovasc Imaging 2018;11:1084–1093.

• Crossref
• PubMed
Henry ML, Niu J, Zhang N, . Cardiotoxicity and cardiac monitoring among chemotherapy-treated breast cancer patients. JACC Cardiovasc Imaging 2018;11:1084–1093.10.1016/j.jcmg.2018.06.00530092967)| false
• Search Google Scholar
• Export Citation

Benson AB, Venook AP, Al-Hawary MM, et al.. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. Version 4.2019. Accessed November 27, 2019. For the most recent version, visit NCCN.org.

• PubMed
Benson AB, Venook AP, Al-Hawary MM, . NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. Version 4.2019. Accessed November 27, 2019. For the most recent version, visit NCCN.org.)| false
• Export Citation

Benson AB, Venook AP, Al-Hawary MM, et al.. NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. Version 4.2019. Accessed November 27, 2019. For the most recent version, visit NCCN.org.

• PubMed
Benson AB, Venook AP, Al-Hawary MM, . NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. Version 4.2019. Accessed November 27, 2019. For the most recent version, visit NCCN.org.)| false
• Export Citation

Survival Rates for Colorectal Cancer. American Cancer Society Website. Available at: https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/survival-rates.html. Accessed November 27, 2019.

• PubMed
Survival Rates for Colorectal Cancer. American Cancer Society Website. Available at: https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/survival-rates.html. Accessed November 27, 2019.)| false
• Export Citation

Sargent D, Sobrero A, Grothey A, et al.. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009;27:872–877.

• Crossref
• PubMed
Sargent D, Sobrero A, Grothey A, . Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009;27:872–877.1912480310.1200/JCO.2008.19.5362)| false
• Search Google Scholar
• Export Citation

Kavalieratos D, Corbelli J, Zhang D, et al.. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA 2016;316:2104–2114.

• Crossref
• PubMed
Kavalieratos D, Corbelli J, Zhang D, . Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA 2016;316:2104–2114.10.1001/jama.2016.1684027893131)| false
• Search Google Scholar
• Export Citation

Temel JS, Greer JA, Muzikansky A, et al.. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733–742.

• Crossref
• PubMed
Temel JS, Greer JA, Muzikansky A, . Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733–742.10.1056/NEJMoa100067820818875)| false
• Search Google Scholar
• Export Citation

Sullivan DR, Chan B, Lapidus JA, et al.. Association of early palliative care use with survival and place of death among patients with advanced lung cancer receiving care in the Veterans Health Administration. JAMA Oncol 2019;5:1702.

• Crossref
• PubMed
Sullivan DR, Chan B, Lapidus JA, . Association of early palliative care use with survival and place of death among patients with advanced lung cancer receiving care in the Veterans Health Administration. JAMA Oncol 2019;5:1702.10.1001/jamaoncol.2019.3105)| false
• Search Google Scholar
• Export Citation

D’Amico AV, Chen MH, Renshaw AA, et al.. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA 2008;299:289–295.

• Crossref
• PubMed
D’Amico AV, Chen MH, Renshaw AA, . Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA 2008;299:289–295.1821231310.1001/jama.299.3.289)| false
• Search Google Scholar
• Export Citation

Denham JW, Steigler A, Lamb DS, et al.. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. Lancet Oncol 2011;12:451–459.

• Crossref
• PubMed
Denham JW, Steigler A, Lamb DS, . Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. Lancet Oncol 2011;12:451–459.10.1016/S1470-2045(11)70063-821440505)| false
• Search Google Scholar
• Export Citation

Jones CU, Hunt D, McGowan DG, et al.. Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med 2011;365:107–118.

• Crossref
• PubMed
Jones CU, Hunt D, McGowan DG, . Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med 2011;365:107–118.2175190410.1056/NEJMoa1012348)| false
• Search Google Scholar
• Export Citation

Ficarra V, Novara G, Ahlering TE, et al.. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 2012;62:418–430.

• Crossref
• PubMed
Ficarra V, Novara G, Ahlering TE, . Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 2012;62:418–430.2274985010.1016/j.eururo.2012.05.046)| false
• Search Google Scholar
• Export Citation

Chade DC, Eastham J, Graefen M, et al.. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 2012;61:961–971.

• Crossref
• PubMed
Chade DC, Eastham J, Graefen M, . Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 2012;61:961–971.10.1016/j.eururo.2012.01.02222280856)| false
• Search Google Scholar
• Export Citation

Shekarriz B, Upadhyay J, Pontes JE. Salvage radical prostatectomy. Urol Clin North Am 2001;28:545–553.

• Crossref
• PubMed
Shekarriz B, Upadhyay J, Pontes JE. Salvage radical prostatectomy. Urol Clin North Am 2001;28:545–553.10.1016/S0094-0143(05)70162-211590813)| false
• Search Google Scholar
• Export Citation

Loeb S, Bruinsma SM, Nicholson J, et al.. Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification. Eur Urol 2015;67:619–626.

• Crossref
• PubMed
Loeb S, Bruinsma SM, Nicholson J, . Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification. Eur Urol 2015;67:619–626.2545701410.1016/j.eururo.2014.10.010)| false
• Search Google Scholar
• Export Citation

Epstein JI, Egevad L, Amin MB, et al.. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 2016;40:244–252.

• PubMed
Epstein JI, Egevad L, Amin MB, . The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 2016;40:244–252.26492179)| false
• Search Google Scholar
• Export Citation

Lu-Yao GL, Albertsen PC, Moore DF, et al.. Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer. JAMA Intern Med 2014;174:1460–1467.

• Crossref
• PubMed
Lu-Yao GL, Albertsen PC, Moore DF, . Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer. JAMA Intern Med 2014;174:1460–1467.10.1001/jamainternmed.2014.302825023796)| false
• Search Google Scholar
• Export Citation

Potosky AL, Haque R, Cassidy-Bushrow AE, et al.. Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol 2014;32:1324–1330.

• Crossref
• PubMed
Potosky AL, Haque R, Cassidy-Bushrow AE, . Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol 2014;32:1324–1330.10.1200/JCO.2013.52.578224638009)| false
• Search Google Scholar
• Export Citation

American College of Surgeons, Commission on Cancer. Cancer Program Standards: Ensuring Patient-Centered Care. Available at: https://www.facs.org/-/media/files/quality-programs/cancer/coc/2016-coc-standards-manual_interactive-pdf.ashx. Accessed December 1, 2019.

• PubMed
American College of Surgeons, Commission on Cancer. Cancer Program Standards: Ensuring Patient-Centered Care. Available at: https://www.facs.org/-/media/files/quality-programs/cancer/coc/2016-coc-standards-manual_interactive-pdf.ashx. Accessed December 1, 2019.)| false
• Export Citation

Abernethy AP, Herndon JE, Wheeler JL, et al.. Poor documentation prevents adequate assessment of quality metrics in colorectal cancer. J Oncol Pract 2009;5:167–174.

• Crossref
• PubMed
Abernethy AP, Herndon JE, Wheeler JL, . Poor documentation prevents adequate assessment of quality metrics in colorectal cancer. J Oncol Pract 2009;5:167–174.10.1200/JOP.094200320856630)| false
• Search Google Scholar
• Export Citation

Lara PN Jr, Higdon R, Lim N, et al.. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728–1733.

• Crossref
• PubMed
Lara PN Jr, Higdon R, Lim N, . Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 2001;19:1728–1733.1125100310.1200/JCO.2001.19.6.1728)| false
• Search Google Scholar
• Export Citation

Secretan B, Straif K, Baan R, et al.. A review of human carcinogens—part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009;10:1033–1034.

• Crossref
• PubMed
Secretan B, Straif K, Baan R, . A review of human carcinogens—part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009;10:1033–1034.10.1016/S1470-2045(09)70326-2)| false
• Search Google Scholar
• Export Citation

Warren GW, Cummings KM. Tobacco and lung cancer: risks, trends, and outcomes in patients with cancer. Am Soc Clin Oncol Educ Book 2013;33:359–364.

• Crossref
• PubMed
Warren GW, Cummings KM. Tobacco and lung cancer: risks, trends, and outcomes in patients with cancer. Am Soc Clin Oncol Educ Book 2013;33:359–364.10.1200/EdBook_AM.2013.33.359)| false
• Search Google Scholar
• Export Citation

Gritz ER, Toll BA, Warren GW. Tobacco use in the oncology setting: advancing clinical practice and research. Cancer Epidemiol Biomarkers Prev 2014;23:3–9.

• Crossref
• PubMed
Gritz ER, Toll BA, Warren GW. Tobacco use in the oncology setting: advancing clinical practice and research. Cancer Epidemiol Biomarkers Prev 2014;23:3–9.10.1158/1055-9965.EPI-13-089624420982)| false
• Search Google Scholar
• Export Citation

Hanna N, Mulshine J, Wollins DS, et al.. Tobacco cessation and control a decade later: American Society of Clinical Oncology policy statement update. J Clin Oncol 2013;31:3147–3157.

• Crossref
• PubMed
Hanna N, Mulshine J, Wollins DS, . Tobacco cessation and control a decade later: American Society of Clinical Oncology policy statement update. J Clin Oncol 2013;31:3147–3157.10.1200/JCO.2013.48.8932)| false
• Search Google Scholar
• Export Citation

Earle CC, Park ER, Lai B, et al.. Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 2003;21:1133–1138.

• Crossref
• PubMed
Earle CC, Park ER, Lai B, . Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol 2003;21:1133–1138.1263748110.1200/JCO.2003.03.059)| false
• Search Google Scholar
• Export Citation

Mack JW, Cronin A, Keating NL, et al.. Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol 2012;30:4387–4395.

• Crossref
• PubMed
Mack JW, Cronin A, Keating NL, . Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol 2012;30:4387–4395.10.1200/JCO.2012.43.6055)| false
• Search Google Scholar
• Export Citation

Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Washington, DC: The National Academies Press, Institute of Medicine; 2015.

• PubMed
Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. Washington, DC: The National Academies Press, Institute of Medicine; 2015.)| false
• Export Citation

Kraut J, Mooney K, Sweetenham JW, et al.. Implementing an electronic end-of-life chemotherapy utilization measure. J Oncol Pract 2019;15:220–223.

• Crossref
• PubMed
Kraut J, Mooney K, Sweetenham JW, . Implementing an electronic end-of-life chemotherapy utilization measure. J Oncol Pract 2019;15:220–223.3088325610.1200/JOP.18.00408)| false
• Search Google Scholar
• Export Citation

Adelson KB, Meropol NJ, Hamrick J, et al.. Development of a dashboard for end-of-life care at an academic hospital [abstract]. J Clin Oncol 2018;36(Suppl):Abstract 6590.

• Crossref
• PubMed
Adelson KB, Meropol NJ, Hamrick J, . Development of a dashboard for end-of-life care at an academic hospital [abstract]. J Clin Oncol 2018;36(Suppl):Abstract 6590.10.1200/JCO.2018.36.15_suppl.6590)| false
• Search Google Scholar
• Export Citation

Porter ME, Larsson S, Lee TH. Standardizing patient outcomes measurement. N Engl J Med 2016;374:504–506.

• Crossref
• PubMed
Porter ME, Larsson S, Lee TH. Standardizing patient outcomes measurement. N Engl J Med 2016;374:504–506.2686335110.1056/NEJMp1511701)| false
• Search Google Scholar
• Export Citation

Hassett MJ. Quality improvement in the era of big data. J Clin Oncol 2017;35:3178–3180.

• Crossref
• PubMed
Hassett MJ. Quality improvement in the era of big data. J Clin Oncol 2017;35:3178–3180.2873797410.1200/JCO.2017.74.1181)| false
• Search Google Scholar
• Export Citation